Last reviewed · How we verify
MORICIZINE HYDROCHLORIDE
At a glance
| Generic name | MORICIZINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1990 |
Approved indications
Common side effects
Key clinical trials
- Cardiac Arrhythmia Suppression Trial (CAST) (PHASE3)
- Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) (PHASE3)
- Cardiac Arrhythmia Pilot Study (CAPS) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MORICIZINE HYDROCHLORIDE CI brief — competitive landscape report
- MORICIZINE HYDROCHLORIDE updates RSS · CI watch RSS